Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 10,035 - -
Change - -44.47% -24.57% -2.31% -10.57% 22.2% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 9,286 9,070 8,928
Change - -47.11% -24.24% -2.91% -9.8% 17.92% -2.33% -1.56%
P/E 5.38x - -14.8x -5.03x 10.9x 45.4x 44.4x 44.7x
PBR - 1.27x 1.05x 1.41x 1.11x - - -
PEG - - - -0x -0x -0.6x 19.44x -63.4x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.91x 3.81x 3.78x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 3.61x 3.45x 3.36x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 22.9x 21.2x 20.6x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 32.2x 28.1x 26.7x
EV / FCF 41.9x 127x 24x - - 30.2x 28.7x 26.9x
FCF Yield 2.39% 0.79% 4.17% - - 3.31% 3.48% 3.71%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.32 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,569 2,632 2,654
EBITDA 1 677.5 667.9 535.9 479.5 453.2 404.7 427.7 432.6
EBIT 1 571.2 524 378.9 331.3 311.6 288.4 323.3 334.4
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 224.8 229.7 228.3
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 377.69 377.69 377.69
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,738 - -
Announcement Date 2/10/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
45.4x3.61x22.95x-.--% 10.03B
28.61x3.96x15.3x2.55% 175B
18.93x3.47x12.41x3.15% 114B
16.64x0.19x12.23x0.78% 57.98B
35.43x3.42x11.72x2.13% 50.07B
28.77x7.1x18.35x1.39% 50.13B
34.75x6.11x19.18x-.--% 32.71B
46x1.3x12.07x0.21% 30.77B
43.81x7.69x27.57x0.24% 26.44B
55.45x7.38x23.73x0.38% 23.96B
Average 35.38x 4.42x 17.55x 1.08% 57.13B
Weighted average by Cap. 29.48x 4.00x 15.46x 1.84%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. Valuation Bio-Rad Laboratories, Inc.